Symptomtext
patient was given FLUZONE QIV T instead of FLUZONE HIGH-DOSE QUADRIVALENT with no AE; Initial information regarding an unsolicited valid non-serious was received from other health professional via Medical Information (Reference number- 00770131) and transmitted to Sanofi on 15-Sep-2021. This case involves a 66 years old patient with unknown gender who was given INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] instead of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (wrong product administered). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 15-Sep-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UJ705AA and expiry date: 30-Jun-2022) via unknown route at an unknown administration site for prophylactic vaccination instead of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number and expiry date were not reported) (wrong product administered). It was reported "Nurse states that a 66 year old patient was given FLUZONE QIV T instead of FLUZONE HIGH-DOSE QUADRIVALENT and wanted to know if any additional protection was required for the patient. Caller asked if the patient needed an additional 0.2 ml since the FLUZONE HIGH-DOSE QUADRIVALENT contains 0.7ml per vaccine. Caller states that she is in the process of reaching out to the patient and wanted to know if she needed to have them return for a second vaccination." It was a case of actual medication error due to wrong vaccine administered (latency: same day). At the time of reporting, the patient experienced no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the legal guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.